G-BRONCO-D is a Oral Suspension in the Human Otc Drug category. It is labeled and distributed by Mclaren Medical Inc. The primary component is Guaifenesin; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride.
| Product ID | 43913-403_509fb31b-09bb-4671-be8f-3dcf1771cbd3 |
| NDC | 43913-403 |
| Product Type | Human Otc Drug |
| Proprietary Name | G-BRONCO-D |
| Generic Name | Guaifenesin, Dextromethorphan Hydrobromide, And Phenylephrine Hydrochloride |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-07-01 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | MCLAREN MEDICAL INC |
| Substance Name | GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient Strength | 200 mg/5mL; mg/5mL; mg/5mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2012-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2012-07-01 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 200 mg/5mL |
| SPL SET ID: | 632d4219-7c36-4ed1-a5d0-7d0021b778a9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43913-403 | G-BRONCO-D | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE |
| 53809-250 | DOMETUSS-G | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE |
| 75834-040 | Nivanex DMX | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE |
| 0904-6309 | Robafen CF Cough and cold | Guaifenesin, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride |